J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 532, Number 3, 583-593, May 1, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rousset, M.
Right arrow Articles by Charnet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rousset, M.
Right arrow Articles by Charnet, P.

Journal of Physiology (2001), 532.3, pp. 583-593
© Copyright 2001 The Physiological Society

Functional roles of gamma2, gamma3 and gamma4, three new Ca2+ channel subunits, in P/Q-type Ca2+ channel expressed in Xenopus oocytes


M. Rousset, T. Cens, S. Restituito, C. Barrere, J. L. Black III *, M. W. McEnery † and P. Charnet


CRBM, CNRS UPR 1086, UFR 24, 1919 Route de Mende, 34293 Montpellier Cedex 05, France, * Department of Psychiatry and Psychology, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA and †Laboratory of Developmental Neurobiochemistry, Department of Physiology Biophysics and Neuroscience, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 4106-4970, USA

MS 11767 Received 9 October 2000; accepted after revision 10 January 2001

  ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

  1. Stargazin or gamma2, the product of the gene mutated in the stargazer mouse, is a homologue of the gamma1 protein, an accessory subunit of the skeletal muscle L-type Ca2+ channel. gamma2 is selectively expressed in the brain, and considered to be a putative neuronal Ca2+ channel subunit based mainly on homology to gamma1. Two new members of the gamma family expressed in the brain have recently been identified: gamma3 and gamma4.
  2. We have co-expressed, in Xenopus oocytes, the human gamma2, gamma3 and gamma4 subunits with the P/Q-type (CaV2.1) Ca2+ channel and different regulatory subunits (alpha2-delta; beta1, beta2, beta3 or beta4).
  3. Subcellular distribution of the gamma subunits confirmed their membrane localization.
  4. Ba2+ currents, recorded using two-electrode voltage clamp, showed that the effects of the gamma subunits on the electrophysiological properties of the channel are, most of the time, minor. However, a fraction of the oocytes expressing beta subunits displayed an unusual slow-inactivating Ba2+ current. Expression of both beta and gamma subunits increased the appearance of the slow-inactivating current.
  5. Our data support a role for the gamma subunit as a brain Ca2+ channel modulatory subunit and suggest that beta and gamma subunits are involved in a switch between two regulatory modes of the P/Q-type channel inactivation.

  INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

Stargazin or gamma2, a protein selectively expressed in the brain with homology to the skeletal muscle L-type Ca2+ channel gamma1 subunit (Bosse et al. 1990; Pragnell et al. 1991) was recently discovered as the product of the gene mutated by insertion of a retrotransposon in the stargazer mouse model of petit mal epilepsy and ataxia (Letts et al. 1998).

In skeletal muscle, gamma1 can be co-immunoprecipitated from muscle extracts with the pore-forming L-type Ca2+ channel subunit alpha1S (Flockerzi et al. 1986a,b; Sieber et al. 1987). The gamma1 subunit is a 32 kDa, 222 amino acid, glycosylated transmembrane protein with 10 cysteines that are supposed to form disulfide bridges of major importance for the secondary structure of the native protein (Bosse et al. 1990; Pragnell et al. 1991). Co-expression of gamma1 with L-type (alpha1C or CaV1.2) or P/Q-type (alpha1A or CaV2.1) Ca2+ channels in heterologous systems has evidenced minor modulatory function including slight changes in the activation and inactivation properties and modification in the peak current amplitude of these Ca2+ channels (Mori et al. 1991; Wei et al. 1991; Singer Lahat et al. 1994; Sipos et al. 1995; Eberst et al. 1997; Ren & Hall, 1997; Freise et al. 2000).

The stargazin protein displays 38 % similarity (25 % identity) with gamma1 and shares the same gene organization and protein secondary structure including four putative transmembrane segments (Letts et al. 1998; Klugbauer et al. 2000). The stargazer mouse has recessively inherited epilepsy and ataxia characterized by spike wave seizures, characteristic of petit mal or absence epilepsy (Chen et al. 1999). Cerebellar disorders have also been noted, including, most prominently, abnormal migration and maturation and reduced brain-derived neurotrophic factor production of cerebellar granule cells. These features are coincindent with the start of ataxia (Qiao et al. 1996, 1998). Immature or reduced synaptic transmission at parallel fibre-Purkinje cell synapses, Golgi cell-granule cell synapses and mossy fibre-granule cell synapses has also been noticed (Chen et al. 1999; Hashimoto et al. 1999), suggesting a crucial role of the gamma2/stargazin protein for normal synaptic transmission. The phenotypic similarities between stargazer mice and the other neurological mutant mice, tottering and lethargic, which have defects in genes encoding the alpha1A and beta4 subunits of the P/Q-type Ca2+ channels, together with the homology of gene and protein structures with the gamma1 subunit, have led to the hypothesis that the gamma2 subunit is indeed a Ca2+ channel subunit and suggest a channel dysfunction as the basis of the disease.

Three new members of this family (gamma3, gamma4 and gamma5) have now been isolated in mice and humans (Black & Lennon, 1999; Klugbauer et al. 2000). Co-expression studies of these four gamma subunits with the L-type (alpha1C) or P/Q-type (alpha1A) Ca2+ channels did not change the kinetics and voltage dependence of activation of the channel (Klugbauer et al. 2000). Analysis of the effects of these gamma subunits on channel inactivation has produced contradictory results, and shifts in the steady-state inactivation curves in both the depolarized and the hyperpolarized direction have been reported, depending on the alpha1 and beta subunits (alpha1A, alpha1C, beta1 or beta2) used, as well as the cation used as charge carrier (Ba2+ versus Ca2+, Klugbauer et al. 2000). These data suggest that the subunit composition of the channel might be an important determinant of the effects of the gamma subunits on channels properties, and therefore on the physiopathological consequences of its absence in the stargazer mice.

In this work we have analysed the effects of human gamma2, gamma3 and gamma4 subunits and the modulatory roles of the beta1, beta2, beta3 and beta4 subunits on P/Q-type Ca2+ channel properties.

  METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

tsA-201 cell transfection and immunocytochemistry

tsA-201 cells (human embryonic kidney cell line) were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) containing 10 % fetal bovine serum and 1 % penicillin-streptomycin at 37 °C in 5 % CO2. Transfections were performed using Superfect (Qiagen, Courtaboeuf, France) according to the manufacturer's protocols, 1 day after plating the cells on poly-L-ornithine-treated 35 mm Petri dishes. Five micrograms of plasmid cDNA(s) were used for each transfection with an incubation time of 2 h. Forty-eight hours later, cells were fixed and permeabilized using PBS supplemented with paraformaldehyde (4 %) and Triton X-100 (0.05 %) applied for 20 and 10 min, respectively. After an incubation of 1 h in PBS + BSA (3 %), cells were incubated for an additional hour with anti-gammacom rabbit polyclonal antibody (cw59), washed three times in PBS and incubated for 1 h with secondary anti-rabbit goat antibody conjugated to Cy3 (Sigma-Aldrich, Saint Quentin Fallavier, France). After three further washes, cells were mounted and viewed on a conventional immunofluorescence microscope.

Xenopus oocyte preparation and injection

Experiments were carried out following national guidelines. Xenopus laevis ovarian lobes were removed from frogs under tricaine methane sulfonate (MS-222, 0.2 %, Sigma-Aldrich) anaesthesia, and placed in a 90 mm Petri dish containing (mM): NaCl, 82.5; KCl, 2; MgCl2, 1; Hepes, 5 (OR-2 solution). Frogs were humanely killed after the final collection. Isolated ovarian lobes were broken into clumps and washed several times with OR-2 solution. They were then incubated at 19 °C under gentle agitation in the collagenase solution (Type 1A, Sigma-Aldrich at 1 mg ml-1 in OR-2 solution) for 1-2 h. After dissociation, oocytes were washed several times in OR-2 solution, and allowed to recover for 1-2 h in medium containing (mM): NaCl, 96; KCl, 2; MgCl2, 2; CaCl2, 1.8; sodium pyruvate, 2.5; Hepes, 5; pH adjusted to 7.4 with NaOH; and supplemented with 50 µg ml-1 gentamicin. Stage V and VI oocytes were selected under a binocular microscope and were usually injected the same day.

The following calcium channel subunits were used: alpha1A (Starr et al. 1991), beta1b (Pragnell et al. 1991), beta2a (Perez Reyes et al. 1992), beta3, beta4 (Castellano et al. 1993a,b) and alpha2-delta (Tomlinson et al. 1993). All these cDNAs were inserted into the pMT2 expression vector (Stea et al. 1994). gamma2, gamma3 and gamma4 subunits were subcloned into pc-DNA3.1. Xenopus oocyte injection (5-10 nl of alpha1 + alpha2-delta + beta ± gamma cDNAs at ~0.3 ng nl-1 each) was performed as described elsewhere (Cens et al. 1996; Restituito et al. 2000). Oocytes were then incubated for 2-7 days at 19 °C under gentle agitation before recording. The incubation medium was renewed daily.

Electrophysiological recordings

Whole-cell Ba2+ currents were recorded under two-electrode voltage clamp using a GeneClamp 500 amplifier (Axon Instruments, Burlingame, CA, USA). Current and voltage electrodes (less than 1 MOmega) were filled with: CsCl, 2.8 M; Hepes, 10 mM; BAPTA, 10 mM; pH adjusted to 7.2 with CsOH. Ba2+ current recordings were performed after injection of BAPTA (around 50 nl of a solution containing (mM): BAPTA free acid (Sigma), 100; CsOH, 10; Hepes, 10; pH adjusted to 7.2 with CsOH) using the following recording solution (mM): BaOH, 10; TEAOH, 20; NMDG, 50; CsOH, 2; Hepes, 10; pH adjusted to 7.2 with methanesulfonic acid. Currents were filtered and digitized using a DMA-Tecmar labmaster interface, and subsequently stored on an IPC 486 personal computer using version 6.02 of the pCLAMP software (Axon Instruments). Ba2+ currents were recorded during a test pulse from -80 mV to +10 mV of 2.5 s duration. Current amplitudes were measured at the peak of the current (I1) and at the end of the pulse (I2). The percentage inactivation was calculated as the ratio of I2/I1. Isochronal inactivation (2.5 s of conditioning depolarization followed by a 400 ms test pulse to +10 mV) was fitted using the following equations:

I/Imax = Rin + (1 - Rin)/(1 + exp((V - E in)/k in)),

where I is the current amplitude measured during the test pulse at +10 mV for conditioning depolarization varying from -80 to +50 mV, Imax is the current amplitude measured during the test pulse for a conditioning depolarization of -80 mV, Ein is the potential for half-inactivation, V is the conditioning depolarization, kin is a slope factor and Rin is the proportion of non-inactivating current. Current-voltage curves were fitted using the following equation:

I = G (V - E rev)/(1 + exp((V - Vact)/kact)),

where I is the current amplitude measured during depolarizations varying from -80 to +50 mV, G is the maximal macroscopic conductance, E rev is the apparent reversal potential, Vact is the potential for half-activation, V is the value of the depolarization and kact is a slope factor.

All values are presented as means ± S.E.M. Student's t test was used at the 0.05 confidence level to determine the significance of the difference between two means.

  RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Several works have reported that the alpha2-delta subunit does not alter the effects of gamma subunits on either P/Q- or L-type Ca2+ channels (Klugbauer et al. 2000). We have therefore expressed the alpha1A (CaV2.1) subunit with the alpha2-delta subunit and each of the possible gamma and beta/gamma combinations (see Fig. 1 for the combinations and nomenclature used).
F1 View larger version
[in this window]
[in a new window]

Figure 1. Schematic representation of all the combinations of subunits used in this study

Between 5 and 35 oocytes were recorded for each combination (except beta4/gamma4, where n = 2 oocytes). ND, not determined.

Membrane expression of gamma subunits

In a first set of experiments, we checked the correct expression and membrane targeting of the three neuronal gamma subunits gamma2, gamma3 and gamma4. It has been recently shown that cytoplasmic beta subunits can be localized at the membrane by association with the alpha1 pore-forming subunit of the channel (Neuhuber et al. 1998). Therefore, to confirm the transmembrane nature of the gamma subunit, we expressed it without co-expression of any other calcium channel subunits. Two days after transfection, expression and localization of each of the gamma subunits was analysed by immunocytochemistry using an anti-gammacom antibody that recognized all three gamma subunits and a secondary antibody coupled to Cy3. In all three cases, a strong expression was noticed. The clear membrane localization of the three gamma subunits seen in Fig. 2 confirms that their putative secondary structure involves transmembrane segments.
F2 View larger version
[in this window]
[in a new window]

Figure 2. Membrane expression of the gamma2, gamma3 and gamma4 subunits

Human gamma2, gamma3 or gamma4 subunit cDNA was transiently transfected into tsA-201 cells. Forty-eight hours after transfections, gamma subunits were detected by immunofluorescence using an anti-gammacom antibody and a secondary antibody labelled with Cy3.

Effects of gamma subunits on Ca2+ channel activation and isochronal inactivation

We then characterized the functional effects of the gamma2 and gamma3 subunits on the voltage-dependent properties of the P/Q-type Ca2+ channels expressed in oocytes after injection of cDNA for alpha1A and alpha2-delta subunits (without expression of any beta subunits). The new neuronal gamma subunits had minor effects on the activation properties, with slight, but significant, hyperpolarizing changes in the voltage dependence of activation (Vact; see Methods) and a decrease in the slope factor kact (see Fig. 3A and column labelled 'No beta' in Table 1). gamma2 and gamma3 subunits also hyperpolarized significantly (P < 0.05) the potential for half-inactivation (E in) by 3-5 mV, increased the inactivation slope factor (k in) and decreased the fraction of non-inactivating current (Rin) in the steady-state inactivation curve (see Fig. 3A and column labelled 'No beta' in Table 2). Therefore the gamma2 and gamma3 subunits hyperpolarized channel activation and increased inactivation.

tab1
F3 View larger version
[in this window]
[in a new window]

Figure 3. Modulation of the alpha1A Ca2+ channel activation and inactivation properties by gamma subunits

The different combinations of subunits used are indicated above the graphs, which show a comparison of current-voltage curves and steady-state inactivation curves in the absence and presence of gamma subunits. A, current-voltage curves were calculated by measuring the peak current amplitudes recorded during test pulses to between -60 and +40 mV (+10 mV increments; holding potential was -80 mV). B, steady-state inactivation curves were obtained during a test pulse to +10 mV after 2.5 s conditioning depolarizations to between -60 and +30 mV (+10 mV increments; see Methods for equations).

These parameters, however, were differentially affected when each of the three neuronal gamma subunits was co-expressed with different beta subunits. Voltage-dependent activation and inactivation parameters were not modified by expression of gamma2, gamma3 and gamma4 subunits, when the beta1b subunit was expressed with the alpha1A/alpha2-delta subunits (except a small but significant depolarization of Vact recorded with beta1/gamma4; see Fig. 3 and Tables 1 and 2). Similarly, activation of beta3-containing channels was not affected by any of the gamma subunits while inactivation was significantly hyperpolarized (E in decreased by ~5 mV for beta3/gamma2 and beta3/gamma4) and increased (see Rin for beta3/gamma2).

Expression of the beta2a subunit induced varying effects on Vact, with no effect (beta2/gamma3) or depolarizing (beta2/gamma2) or hyperpolarizing (beta2/gamma4) shifts. These shifts were accompanied by a significant increase in the slope factor, and, in the case of beta/gamma2, a depolarizing shift in the inactivation curve. Interestingly, all three gamma subunits induced a decrease in inactivation when beta2a was expressed (see Rin in Table 2).

tab2

With alpha1A + alpha2-delta + beta4 subunit combinations, no effects on channel activation and inactivation parameters (Vact, kact, E in, k in and Rin; see Tables 1 and 2) were recorded when gamma3 or gamma4 subunits were co-expressed (beta4/gamma3, beta4/gamma4). The expression of the gamma2 subunits, however, induced a significant depolarizing shift in activation and inactivation (beta4/gamma2).

Therefore, the effects of the different gamma subunits are specific to beta subunits and pleiotropic, in the sense that a reduction or increase in the percentage of non-inactivating current and hyperpolarization or depolarization of the potential for half-inactivation can be recorded. Interestingly, except for a significant increase in Rin with the beta2/gamma3 combination, the gamma3 subunit did not seem to have any significant effect on either activation or inactivation of the channel when a beta subunit was expressed.

Effects of gamma subunits on Ca2+ channel inactivation kinetics

The changes in the steady-state inactivation properties suggest that normal gating kinetics of the Ca2+ channel might be affected by co-expression of the gamma subunits. Although a fine analysis of Ca2+ channel activation kinetics cannot be achieved using the Xenopus oocyte system, a perfectly good analysis of the inactivation kinetics of these different combinations of subunits can be made. This was done by recording Ba2+ currents during long depolarizing pulses (2.5 s at +10 mV; see Fig. 4), and by a subsequent fit of these traces by the sum of two exponential functions. I2/I1, the ratio of the non-inactivating current at the end of the pulse to the peak current, was used as an index of the speed of inactivation, while the fast and slow time constants of inactivation, and relative importance of the slow component (tau1, tau2 and % tau2, respectively) allowed a more precise analysis.
F4 View larger version
[in this window]
[in a new window]

Figure 4. Modulation of inactivation kinetics by gamma subunits

Left panel in A, time course of normalized Ba2+ currents recorded from cells expressing different subunit combinations evoked by step deplarizations of 2.5 s duration to +10 mV. Right panel in A, non-inactivating current at 2.5 s (I2/I1) calculated for oocytes expressing different subunits during a depolarization to +10 mv (holding potential -80 mV). B, the inactivating phase of the current was adjusted to a bi-exponential decay. tau1, fast time constant of inactivation; tau2, slow time constant of inactivation; %tau2, percentage of the slow part of the inactivation. * Significantly different from control (P < 0.05).

As shown on Fig. 4A, when no beta subunit was expressed, both gamma2 and gamma3 induced a significant acceleration of inactivation (see I2/I1). This acceleration was due to a decrease in both tau1 and tau2, together with a decrease in the proportion of tau2 (% tau2; see Fig. 4B).

gamma2, gamma3 and gamma4 did not produce any changes, on average, in the kinetics of inactivation (see I2/I1, tau1, tau2 and % tau2; Fig. 4), when beta3 or beta4 was expressed with the alpha1A and alpha2-delta subunits. gamma3 was also without effect (P > 0.05) on channels containing the beta1 or beta2a subunits. However, expression of the beta/gamma subunit combinations beta1/gamma2, beta2/gamma2 and beta2/gamma4 produced a significant increase in I2/I1. This increase was due to an increase in both the slow time constant of inactivation and the relative amplitude of this time constant (tau2 and % tau2; see Fig. 4). In all cases the fast time constant of inactivation was either not affected or reduced (Fig. 4; combinations no beta/gamma2, beta1/gamma2, beta1/gamma3, beta1/gamma4, beta2/gamma2 and beta3/gamma4).

Unexpected slow inactivation preferentially recorded with gamma subunits

In view of these results, it appears that the regulation of the P/Q-type Ca2+ channel by the neuronal gamma subunits is complex, with small, but specific, modifications of the activation and inactivation properties. However, a statistical comparison of the averaged parameters of these different combinations gave only a partial picture of the variability of our results. Indeed, when looking at individual traces, we noticed that some of our recordings displayed unusual slow inactivation. This slow inactivation was recorded particularly in oocytes expressing a gamma subunit, and can be seen in Fig. 5A, where 20 inactivation curves, recorded from 10 different oocytes expressing beta3/no gamma or beta3/gamma3 subunits are displayed. We thus decided to analyse separately the fast- and slow-inactivating currents. Rin > 20 % was chosen as the criterion for defining slow-inactivating currents for combinations containing no beta subunits, or beta1, beta3 or beta4 subunits. This criterion was increased to Rin > 50 %, when the beta2 subunit was expressed. Slow inactivation was never seen when no beta subunit was expressed, whether a gamma subunit was expressed or not (see Fig. 5B; n = 16, 15 and 15 for no beta, no beta/gamma2 and no beta/gamma3, respectively). When beta subunits were expressed, but without gamma, it was only rarely seen (beta1, 2/22; beta2, 0/16; beta3, 1/28; beta4, 0/5). However, the probability of having slow-inactivating currents was clearly increased by expression of a given gamma subunit. This probability was larger with gamma2 in the combination beta1/gamma2 and beta4/gamma2 , and with gamma3 and gamma4 in the combinations beta2/gamma3, beta2/gamma4, beta3/gamma3 and beta3/gamma4. Although the variable sizes of these populations did not allow a precise comparison of these probabilities, the effects of the gamma subunits were clear.
F5 View larger version
[in this window]
[in a new window]

Figure 5. Two types of inactivation favoured by expression of the gamma subunit

A, steady-state inactivation curves recorded from 20 different oocytes expressing the beta3/no gamma (left) or beta3/gamma3 (right) subunits. Note the presence of oocytes with decreased inactivation in the beta3/gamma3 population. B, bar graph showing the probability of appearance of the slow inactivating currents for different combinations of subunits.

We thus performed a separate analysis of fast- and slow-inactivating currents for the beta3-containing combinations of subunits. In control conditions (see control (beta3/no gamma) in Tables 3 and 4), the fast- and slow-inactivating currents can be separated by only one distinctive steady-state property, the fraction of non-inactivating current, Rin. Expression of gamma2, gamma3 or gamma4 subunits did not change the voltage dependence of activation of both fast- and slow-inactivating currents, but significantly reduced both voltage dependence of inactivation (E in) and Rin, for fast inactivating currents (see Table 3). These effects were similar to those seen without beta subunits expressed. Statistical analysis of the slow current was not performed due to the small size of the population, but activation and inactivation did not appear to be strongly modified (see Table 4).

tab3
tab4

Kinetic properties of fast and slow currents recorded with beta3 were also analysed. As seen in Fig. 6, for fast beta3 currents, tau1 and tau2 (fast and slow time constants of inactivation, respectively) were significantly reduced by expression of gamma3 or gamma4, while %tau2 remained unchanged. These reductions accounted for the increase in inactivation recorded upon expression of the gamma subunit in the fast population. In the slow population, tau2 was significantly increased with all gamma subunits, and other parameters were not modified.
F6 View larger version
[in this window]
[in a new window]

Figure 6. Separate analysis of fast- and slow-inactivating currents for beta3-containing channels

Averaged tau1, tau2 and %tau2 calculated from oocytes expressing beta3/no gamma (control), beta3/gamma2, beta3/gamma3 and beta3/gamma4 combinations. Left panels (fast beta3), analysis of the fast-inactivating current (I2/I1 < 0.2). Right panels (slow beta3), slow-inactivating currents (I2/I1 > 0.2).

Lack of direct beta/gamma interaction

The possibility of direct interaction between the beta1 subunit and gamma2, gamma3 or gamma4 subunits was tested by immunocytochemistry. The beta1 subunit has a cytoplasmic localization when expressed alone. Due to direct protein-protein interaction, this localization is redistributed to the membrane when the alpha1A subunit is co-expressed (Gao et al. 1999). Direct beta/gamma interaction would thus be expected to relocalize the beta1 subunit to the membrane in a beta/gamma co-transfection experiment. We performed this experiment in tsA-201 cells by co-transfection of the beta1 and gamma2, gamma3 or gamma4 subunits. Immunostaining with an anti-beta subunit antibody (Vance et al. 1998) revealed that expression of gamma subunits (gamma2, gamma3 or gamma4; see Fig. 7) did not change the cytoplasmic localization of beta1, suggesting that there was no direct interaction between the two subunits.
F7 View larger version
[in this window]
[in a new window]

Figure 7. Lack of direct beta/gamma interaction in tsA-201 cells

Cells were transfected with the beta1 subunit alone or with gamma2, gamma3 or gamma4 subunit cDNA. Forty-eight hours after transfection, cells were fixed and permeabilized. Localization of the beta1 subunit was done using an anti-beta1 subunit antibody and a secondary antibody coupled to Cy3. Immunofluorescence images show the cytoplasmic localization of the beta1 subunit, even in the presence of membrane-localized gamma subunits, suggesting no direct interaction.

  DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

We show in this study that coexpression of the gamma2, gamma3 and gamma4 subunits with the alpha1A, alpha2-delta and beta subunits modified channel properties in a beta subunit-specific manner in two different ways. (1) When no beta subunits were expressed, gamma2 and gamma3 induced a small negative shift of the inactivation curve and an acceleration of the inactivation kinetics. (2) When beta subunits were expressed, these basic effects were still present but, in some oocytes, Ca2+ channels displayed an unusual slow inactivation, never seen in the absence of beta subunits (0/46). gamma subunits increased the proportion of oocytes expressing these slow-inactivating Ca2+ channels.

The intrinsic effects of the gamma subunits (when the slow-inactivating currents are removed from the analysis) are an acceleration of inactivation and a small hyperpolarizing shift in the inactivation curves. The global effects (taking the slow-inactivating current into consideration) depend largely on the proportion of these slow currents and on the specific beta subunit expressed.

gamma subunit-induced shift in inactivation

The basic effects of gamma (gamma2, gamma3 and gamma4) subunits on alpha1A, alpha1G and alpha1C subunits have recently been reported by Letts et al. (1998) and Klugbauer et al. (2000). These effects are qualitatively similar to those of skeletal muscle gamma1 subunits on the alpha1S, alpha1C or alpha1A subunits (Singer et al. 1991; Mori et al. 1991; Wei et al. 1991; Sipos et al. 1995; Eberst et al. 1997). Studies performed using oocytes or transfected cells, and beta1b or beta2a subunits gave essentially the same results, suggesting that these effects are independent of the expression system used and subunits expressed. The only exception is the depolarizing shift recorded with the beta2/gamma2 combination (see Table 2). A positive shift for this combination was also seen by Klugbauer et al. (2000), but only using Ba2+ as the charge carrier, with a negative shift being recorded when Ca2+ replaced Ba2+. Negative charges are present in the first extracellular loop of all gamma subunits. These charges have been proposed to participate, by modification of the local surface potential, in the observed shift in inactivation properties (Singer et al. 1991). Such modifications are sensitive to the concentrations and types of cations used in the external solutions, and their impact on channel properties is influenced by the subunit composition of the channel (Mangoni et al. 1997; Cens et al. 1998). Although the overall primary sequence in the skeletal muscle gamma1 subunit is poorly conserved in gamma2, gamma3 and gamma4 subunits (25 % identity), preservation of the extracellular negative charge and glycosylation sites and the non-specific nature of these surface potential effects may explain the lack of gamma subunit specificity. However, varying effects with different beta subunits may arise from their specific influence on the sensing of the surface charges by the channel gating machinery (Cens et al. 1998).

The unexpected slow inactivation

The recording of unusual slow-inactivating currents is more puzzling. This type of current kinetics was recorded in the absence of gamma subunits in a very small proportion of oocytes (3/72), but required the expression of a beta subunit (no recordings of slow inactivation without beta subunit expression were obtained, n = 46). These data suggest that the mechanism and the molecular determinants underlying this type of inactivation are present in the alpha1/beta subunit complex, although we did not try to analyse the requirement for an alpha2-delta subunit. The subunit specificity of this type of inactivation has not been tested directly because of its very low frequency of appearance, but our recordings made with gamma subunits suggest that slow inactivation can be recorded with all four beta subunit types.

Recently, it has been shown that P/Q-type Ca2+ channels expressed in tsA-201 cells (alpha1A + alpha2-delta + beta2) display large variations in their kinetics and voltage dependence of inactivation (Hurley et al. 2000). Similar variations were also recorded in bovine chromaffin cells, in more physiological conditions, and were attributed to dynamic palmitoylation of two cysteines of crucial importance for the beta2a-induced slowing of inactivation (Hurley et al. 2000). Under our conditions, the fact that slow inactivation was recorded with and without beta2a subunits makes the participation of beta subunit palmitoylation very unlikely and rather suggests another regulatory mechanism for reducing channel inactivation. This mechanism, however, may act in concert with the beta2a subunit to induce, for the combinations of subunits investigated by us in oocytes, a very slow inactivation.

Molecular events of the slow inactivation

Interestingly, when beta subunits were expressed, gamma subunits increased the frequency of this slow inactivation although no strong direct beta/gamma interaction could be revealed by co-expression in tsA-201 cells (see Fig. 7). Three important questions thus arise. (1) What are the molecular events involved in the slow inactivation? (2) What type of modulation inhibits this slow inactivation in most of the oocytes? (3) What is the role for the gamma subunit in the slow inactivation?

Fast, voltage-dependent, inactivation of the alpha1A subunit is the result of molecular rearrangements involving the I-II loop and the C-terminus of the alpha1 subunit (Zhang et al. 1994; Cens et al. 1999; Bourinet et al. 1999). The beta2a subunit induces a reduction of this type of inactivation by immobilization of the I-II loop, supposed to act as a pore blocker in a similar way to the ball-and-chain model proposed for Shaker K+ channel inactivation. Both a single valine insertion and a point mutation in the I-II loop are known to reduce inactivation drastically without disturbing, qualitatively, regulation of inactivation by beta subunits (Herlitze et al. 1997; Bourinet et al. 1999). Such amino acid changes modify the I-II loop organization and could therefore decrease the affinity of this pore blocker for its binding site. The 'natural' slow inactivation recorded under our conditions could result from such structural changes occurring without the necessity of mutation, by natural modification of either the pore-blocker particle or its binding site. Possible triggering events for this type of modification are phosphorylation, or oxido-reduction changes, bringing new charges or new disulfide bonds into the target sequences. Indeed, multiple reports have already shown in Shaker K+ channels that these types of modifications could influence inactivation kinetics and protein kinase A phosphorylation is known to modulate L-type Ca2+ channel inactivation. gamma subunits could possibly act as catalysts of such reactions, optimizing channel secondary/tertiary structures for modification. A direct effect of the gamma subunit on channel inactivation cannot be discarded, but, as is the case for the beta2a subunit, would require a direct alpha1/gamma interaction, which has yet to be demonstrated. It should be noted that the small proportion of oocytes expressing the slow inactivation will complicate future analysis of these mechanisms.

The presence of the slow-inactivating current suggests an equilibrium between two gating modes of the P/Q-type Ca2+ channels, such as those described for L-type Ca2+ channels (Hess et al. 1984). Bay-K8644, a dihydropyridine agonist of L-type Ca2+ channels, favours preferentially the slow gating mode of the channel (mode II), whose presence is otherwise only very rarely observed. Similar gating modes have also been proposed for P/Q-type Ca2+ channels, but the physiological agents which facilitate the switch between these two modes remain to be identified. However, the slow inactivation should be undoubtedly of primary importance for Ca2+ homeostasis in the particular situations where it is induced. It may be related to the episodic nature of the absence seizures found in mice and underlines the regulatory role the gamma subunits in this phenomenon and the physiopathology of the stargazer mouse. Based on the present data, chronic (basic) and phasic effects acting in opposite directions can be expected to result from suppression of gamma subunits.

In pathological situations, the loss of gamma subunit expression should cause Ca2+ channels to inactivate more slowly and at more depolarized potentials, thus increasing the number of active channels and the Ca2+ influx at a given resting potential. Such modifications, together with the change in the AMPA receptor expression and targeting (Chen et al. 2000), could produce alteration of transmitter release and neuronal excitability. In normal, physiological conditions, when the gamma subunits are expressed, it is clear that conditions where unexpected slow inactivation is favoured will also have important consequences on neuronal Ca2+ homeostasis. Further experiments are clearly required to understand the physiological significance and molecular pathway of this new regulation.

  REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

BLACK J. L. III & LENNON, V. A. (1999). Identification and cloning of putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits: neurologic implications. Mayo Clinic Proceedings 74, 357-361 [Medline]
BOSSE E., REGULLA, S., BIEL, M., RUTH, P., MEYER, H. E., FLOCKERZI, V. & HOFMANN, F. (1990). The cDNA and deduced amino acid sequence of the gamma subunit of the L-type calcium channel from rabbit skeletal muscle. FEBS Letters 267, 153-156 [Medline]
BOURINET E., SOONG, T. W., SUTTON, K., SLAYMAKER, S., MATHEWS, E., MONTEIL, A., ZAMPONI, G. W., NARGEOT, J. & SNUTCH, T. P. (1999). Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nature Neuroscience 2, 407-415 [Medline]
CASTELLANO A., WEI, X., BIRNBAUMER, L. & PEREZ REYES, E. (1993a). Cloning and expression of a third calcium channel beta subunit. Journal of Biological Chemistry 268, 3450-3455 [Abstract]
CASTELLANO A., WEI, X., BIRNBAUMER, L. & PEREZ REYES, E. (1993b). Cloning and expression of a neuronal calcium channel beta subunit. Journal of Biological Chemistry 268, 12359-12366 [Abstract]
CENS T., DALLE, C. & CHARNET, P. (1998). Expression of beta subunit modulates surface potential sensing by calcium channels. Pflügers Archiv 435, 865-867 [Medline]
CENS T., MANGONI, M. E., RICHARD, S., NARGEOT, J. & CHARNET, P. (1996). Coexpression of the beta2 subunit does not induce voltage- dependent facilitation of the class C L-type Ca channel. Pflügers Archiv 431, 771-774 [Medline]
CENS T., RESTITUITO, S., GALAS, S. & CHARNET, P. (1999). Voltage and calcium use the same molecular determinants to inactivate calcium channels. Journal of Biological Chemistry 274, 5483-5490 [Abstract/Full Text]
CHEN L., BAO, S., QIAO, X. & THOMPSON, R. F. (1999). Impaired cerebellar synapse maturation in waggler, a mutant mouse with a disrupted neuronal calcium channel gamma subunit. Proceedings of the National Academy of Sciences of the USA 96, 12132-12137 [Abstract/Full Text]
CHEN L., CHETKOVICH, D. M., PETRALIA, R. S., SWEENEY, N. T., KAWASAKI, Y., WENTHOLD, R. J., BREDT, D. S. & NICOLL, R. A. (2000). Stargazing regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature 408, 936-943 [Medline]
EBERST R., DAI, S., KLUGBAUER, N. & HOFMANN, F. (1997). Identification and functional characterization of a calcium channel gamma subunit. Pflügers Archiv 433, 633-637 [Medline]
FLOCKERZI V., OEKEN, H. J. & HOFMANN, F. (1986a). Purification of a functional receptor for calcium-channel blockers from rabbit skeletal-muscle microsomes. European Journal of Biochemistry 161, 217-224 [Abstract]
FLOCKERZI V., OEKEN, H. J., HOFMANN, F., PELZER, D., CAVALIE, A. & TRAUTWEIN, W. (1986b). Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel. Nature 323, 66-68 [Medline]
FREISE D., HELD, B., WISSENBACH, U., PFEIFER, A., TROST, C., HIMMERKUS, N., SCHWEIG, U., FREICHEL, M., BIEL, M., HOFMANN, F., HOTH, M. & FLOCKERZI, V. (2000). Absence of the gamma subunit of the skeletal muscle dihydropyridine receptor increases L-type Ca2+ currents and alters channel inactivation properties. Journal of Biological Chemistry 275, 14476-14481 [Abstract/Full Text]
GAO T., CHIEN, A. J. & HOSEY, M. M. (1999). Complexes of the alpha1C and beta subunits generate the necessary signal for membrane targeting of class C L-type calcium channels. Journal of Biological Chemistry 274, 2137-2144 [Abstract/Full Text]
HASHIMOTO K., FUKAYA, M., QIAO, X., SAKIMURA, K., WATANABE, M. & KANO, M. (1999). Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. Journal of Neurosciences 19, 6027-6036
HERLITZE S., HOCKERMAN, G.H., SCHEUER, T. & CATTERALL, W. A. (1997). Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel alpha1A subunit. Proceedings of the National Academy of Sciences of the USA 94, 1512-1516 [Abstract/Full Text]
HESS P., LANSMAN, J. B. & TSIEN, R. W. (1984). Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 311, 538-544 [Medline]
HURLEY J. H., CAHILL, A. L., CURRIE, K. P. & FOX, A. P. (2000). The role of dynamic palmitoylation in Ca2+ channel inactivation. Proceedings of the National Academy of Sciences of the USA 97, 9293-9298 [Abstract/Full Text]
KLUGBAUER N., DAI, S., SPECHT, V., LACINOVA, L., MARAIS, E., BOHN, G. & HOFMANN, F. (2000). A family of gamma-like calcium channel subunits. FEBS Letters 470, 189-197 [Medline]
LETTS V. A., FELIX, R., BIDDLECOME, G. H., ARIKKATH, J., MAHAFFEY, C. L., VALENZUELA, A., BARTLETT, F. S., MORI, Y., CAMPBELL, K. P. & FRANKEL, W. N. (1998). The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nature Genetics 19, 340-347 [Medline]
MANGONI M. E., CENS, T., DALLE, C., NARGEOT, J. & CHARNET, P. (1997). Characterisation of alpha1A Ba2+, Sr2+ and Ca2+ currents recorded with ancillary beta1-4 subunits. Receptors and Channels 5, 1-14 [Medline]
MORI Y., FRIEDRICH, T., KIM, M. S., MIKAMI, A., NAKAI, J., RUTH, P., BOSSE, E., HOFMANN, F., FLOCKERZI, V., FURUICHI, T. et al. (1991). Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350, 398-402 [Medline]
NEUHUBER B., GERSTER, U., MITTERDORFER, J., GLOSSMANN, H. & FLUCHER, B. E. (1998). Differential effects of Ca2+ channel beta1a and beta2a subunits on complex formation with alpha1S and on current expression in tsA201 cells. Journal of Biological Chemistry 273, 9110-9118 [Abstract/Full Text]
PEREZ REYES E., CASTELLANO, A., KIM, H. S., BERTRAND, P., BAGGSTROM, E., LACERDA, A. E., WEI, X. Y. & BIRNBAUMER, L. (1992). Cloning and expression of a cardiac/brain beta subunit of the L-type calcium channel. Journal of Biological Chemistry 267, 1792-1797 [Abstract]
PRAGNELL M., SAKAMOTO, J., JAY, S. D. & CAMPBELL, K. P. (1991). Cloning and tissue-specific expression of the brain calcium channel beta-subunit. FEBS Letters 291, 253-258 [Medline]
QIAO X., CHEN, L., GAO, H., BAO, S., HEFTI, F., THOMPSON, R. F. & KNUSEL, B. (1998). Cerebellar brain-derived neurotrophic factor-TrkB defect associated with impairment of eyeblink conditioning in Stargazer mutant mice. Journal of Neurosciences 18, 6990-6999
QIAO X., HEFTI, F., KNUSEL, B. & NOEBELS, J. L. (1996). Selective failure of brain-derived neurotrophic factor mRNA expression in the cerebellum of stargazer, a mutant mouse with ataxia. Journal of Neurosciences. 16, 640-648
REN D. & HALL, L. M. (1997). Functional expression and characterization of skeletal muscle dihydropyridine receptors in Xenopus oocytes. Journal of Biological Chemistry 272, 22393-22396 [Abstract/Full Text]
RESTITUITO S., CENS, T., BARRERE, C., GEIB, S., GALAS, S., DE WAARD, M. & CHARNET, P. (2000). The beta2a subunit is a molecular room for the Ca2+ channel inactivation gate. Journal of Neurosciences 20, 9046-9052
SIEBER M., NASTAINCZYK, W., ZUBOR, V., WERNET, W. & HOFMANN, F. (1987). The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel. European Journal of Biochemistry 167, 117-122 [Abstract]
SINGER D., BIEL, M., LOTAN, I., FLOCKERZI, V., HOFMANN, F. & DASCAL, N. (1991). The roles of the subunits in the function of the calcium channel. Science 253, 1553-1557 [Medline]
SINGER LAHAT D., LOTAN, I., BIEL, M., FLOCKERZI, V., HOFMANN, F. & DASCAL, N. (1994). Cardiac calcium channels expressed in Xenopus oocytes are modulated by dephosphorylation but not by cAMP-dependent phosphorylation. Receptors and Channels 2, 215-226 [Medline]
SIPOS I., JURKAT-ROTT, K., HARASZTOSI, C., FONTAINE, B., KOVACS, L., MELZER, W. & LEHMANN-HORN, F. (1995). Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes. Journal of Physiology 483, 299-306 [Abstract]
STARR T. V., PRYSTAY, W. & SNUTCH, T. P. (1991). Primary structure of a calcium channel that is highly expressed in the rat cerebellum. Proceedings of the National Academy of Sciences of the USA 88, 5621-5625 [Abstract]
STEA A., TOMLINSON, W. J., SOONG, T. W., BOURINET, E., DUBEL, S. J., VINCENT, S. R. & SNUTCH, T. P. (1994). Localization and functional properties of a rat brain alpha 1A calcium channel reflect similarities to neuronal Q- and P-type channels. Proceedings of the National Academy of Sciences of the USA 91, 10576-10580 [Medline]
TOMLINSON W. J., STEA, A., BOURINET, E., CHARNET, P., NARGEOT, J. & SNUTCH, T. P. (1993). Functional properties of a neuronal class C L-type calcium channel. Neuropharmacology 32, 1117-1126 [Medline]
VANCE C. L., BEGG, C. M., LEE, W. L., HAASE, H., COPELAND, T. D. & MCENERY, M. W. (1998). Differential expression and association of calcium channel alpha1B and beta subunits during rat brain ontogeny. Journal of Biological Chemistry 273, 14495-14502 [Abstract/Full Text]
WEI X. Y., PEREZ-REYES, E., LACERDA, A. E., SCHUSTER, G., BROWN, A. M. & BIRNBAUMER, L. (1991). Heterologous regulation of the cardiac Ca2+ channel alpha 1 subunit by skeletal muscle beta and gamma subunits. Implications for the structure of cardiac L-type Ca2+ channels. Journal of Biological Chemistry 266, 21943-21947 [Abstract]
ZHANG J. F., ELLINOR, P. T., ALDRICH, R. W. & TSIEN, R. W. (1994). Molecular determinants of voltage-dependent inactivation in calcium channels. Nature 372, 97-100 [Medline]

Acknowledgements

This work was supported by MENESR, FRM and GRRC (financial support to M.R., T.C. and S.R.), Ligue Régionale contre le Cancer (Pyrénées Orientales), Association pour le Recherche contre le Cancer and Association Française contre les Myopathies.

Corresponding author

P. Charnet: CRBM, CNRS UPR 1086, UFR 24, 1919 Route de Mende, 34293 Montpellier Cedex 05, France.

Email: charnet{at}crbm.cnrs-mop.fr


This article has been cited by other articles:


Home page
J. Neurosci.Home page
A. Sandoval, A. Andrade, A. M. Beedle, K. P. Campbell, and R. Felix
Inhibition of Recombinant N-Type CaV Channels by the {gamma}2 Subunit Involves Unfolded Protein Response (UPR)-Dependent and UPR-Independent Mechanisms
J. Neurosci., March 21, 2007; 27(12): 3317 - 3327.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. W. Tedford and G. W. Zamponi
Direct G Protein Modulation of Cav2 Calcium Channels
Pharmacol. Rev., December 1, 2006; 58(4): 837 - 862.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S.-N. Yang and P.-O. Berggren
The Role of Voltage-Gated Calcium Channels in Pancreatic {beta}-Cell Physiology and Pathophysiology
Endocr. Rev., October 1, 2006; 27(6): 621 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Deng, M. G. Price, C. F. Davis, M. Mori, and D. L. Burgess
Stargazin and other transmembrane AMPA receptor regulating proteins interact with synaptic scaffolding protein MAGI-2 in brain.
J. Neurosci., July 26, 2006; 26(30): 7875 - 7884.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. Khosravani and G. W. Zamponi
Voltage-gated calcium channels and idiopathic generalized epilepsies.
Physiol Rev, July 1, 2006; 86(3): 941 - 966.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Price, C. F. Davis, F. Deng, and D. L. Burgess
The {alpha}-Amino-3-hydroxyl-5-methyl-4-isoxazolepropionate Receptor Trafficking Regulator "Stargazin" Is Related to the Claudin Family of Proteins by Its Ability to Mediate Cell-Cell Adhesion
J. Biol. Chem., May 20, 2005; 280(20): 19711 - 19720.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
S. Luvisetto, T. Fellin, M. Spagnolo, B. Hivert, P. F. Brust, M. M. Harpold, K. A. Stauderman, M. E. Williams, and D. Pietrobon
Modal Gating of Human CaV2.1 (P/Q-type) Calcium Channels: I. The Slow and the Fast Gating Modes and their Modulation by {beta} Subunits
J. Gen. Physiol., October 25, 2004; 124(5): 445 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
T. Fellin, S. Luvisetto, M. Spagnolo, and D. Pietrobon
Modal Gating of Human CaV2.1 (P/Q-type) Calcium Channels: II. The b Mode and Reversible Uncoupling of Inactivation
J. Gen. Physiol., October 25, 2004; 124(5): 463 - 474.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. C. Stotz, S. E. Jarvis, and G. W. Zamponi
Functional roles of cytoplasmic loops and pore lining transmembrane helices in the voltage-dependent inactivation of HVA calcium channels
J. Physiol., January 15, 2004; 554(2): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-G. Kang and K. P. Campbell
{gamma} Subunit of Voltage-activated Calcium Channels
J. Biol. Chem., June 6, 2003; 278(24): 21315 - 21318.
[Full Text] [PDF]


Home page
J. Cell Biol.Home page
S. Tomita, L. Chen, Y. Kawasaki, R. S. Petralia, R. J. Wenthold, R. A. Nicoll, and D. S. Bredt
Functional studies and distribution define a family of transmembrane AMPA receptor regulatory pr